oral glp-1 medications approved BREAKING: The FDA has the first pill for obesity, marking a major milestone in the weight-loss drug market and a potential inflection point for treatment access. The daily pill Oral GLP-1 Medication Helps Patients

A different non-insulin injectable diabetes medication Victoza (liraglutide) was approved in 2010, but in 2013, the FDA issued a warning to consumers of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas. And this first warning isnt an anomaly

Discontinue Byetta if pancreatitis is suspected Notes: The discovery of DPP-IV-resitant GLP-1 analogs was pursued in parallel with the discovery of DPP-IV inhibitors

Doctor-developed bundle cultivating targeted restoration across the Gut-Metabolic Axis: GLP-1 boosting + Weight Support + Digestive Support + Heart and Circulatory Support + Caffeine-Free Energy

Nearly 40% of adults age 60 and older qualified as obese in 2023, according to the Centers for Disease Control and Prevention